Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
University of Wisconsin, Madison
Duke University
AEterna Zentaris
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00776867
First received: October 20, 2008
Last updated: September 19, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)